Related Experiment Video
Updated: May 8, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
[Unusual presentation of a severe Mycoplasma pneumoniae infection: report of 2 cases]
J Prunier-Duparge1, A Desrumaux, T Debillon
1Clinique universitaire de pédiatrie du CHU de Grenoble, BP 217, 38043 Grenoble cedex 9, France; Service de réanimation pédiatrique et de surveillance continue pédiatrique du CHU de Grenoble, BP 217, 38043 Grenoble cedex 9, France.
Abstract:
Mycoplasma pneumonia is responsible for multisystemic infection. Pulmonary symptoms are most common in children. We describe herein two unusual severe forms of M. pneumoniae infection without initial pulmonary symptoms. The first case is an 8-month-old boy who was hospitalized in the pediatric intensive care unit with severe sepsis. There were no initial pulmonary symptoms, nor obvious clinical infection. Initial blood tests and x-ray did not aid the diagnosis. The blood tests came back positive for M. pneumonia. Pulmonary symptoms eventually appeared 24h later, and there was a pneumonia outbreak on the chest radiograph. The boy was given josamycin and improved quickly. The second case concerns an 8-year-old child who was hospitalized in the pediatric intensive care unit with toxic shock. No clinical infectious origin was found. A broad-spectrum antibiotic therapy was started with ceftriaxone and josamycin. The M. pneumoniae blood test came back positive, which confirmed the diagnosis of septic shock in M. pneumoniae, requiring adjustment of the antibiotic therapy. Current guidelines for the choice of probabilistic antibiotic therapy in case of severe sepsis do not include the case of M. pneumoniae. The early initiation of antibiotic therapy plays a major role in the prognosis of these patients. It seems useful to search for M. pneumoniae in cases of severe atypical infections, particularly in the absence of pulmonary symptoms.
Insights
Mycoplasma pneumoniae can cause severe sepsis and toxic shock in children, even without initial lung symptoms. Early diagnosis and treatment are crucial for better outcomes in these atypical infections.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Critical Care Medicine
Background:
- Mycoplasma pneumoniae typically causes respiratory illness in children.
- Severe, multisystemic M. pneumoniae infections, especially without pulmonary symptoms, are uncommon.
- Current sepsis guidelines may not adequately address M. pneumoniae as a causative agent.
Observation:
- Two pediatric intensive care unit cases of severe M. pneumoniae infection presented without initial pulmonary symptoms.
- Case 1: An infant with severe sepsis initially lacked clear infection signs; M. pneumoniae was diagnosed after pulmonary symptoms emerged.
- Case 2: A child presented with toxic shock; M. pneumoniae infection was confirmed via blood testing, necessitating antibiotic adjustment.
Findings:
- M. pneumoniae can manifest as severe sepsis or toxic shock in children.
- Diagnosis can be delayed if pulmonary symptoms are absent.
- Blood testing is vital for identifying M. pneumoniae in atypical severe infections.
Implications:
- Consider M. pneumoniae in severe pediatric sepsis and toxic shock, even without respiratory signs.
- Early antibiotic therapy, guided by prompt M. pneumoniae testing, is critical for patient prognosis.
- Guidelines for empirical antibiotic therapy in severe sepsis may need revision to include M. pneumoniae.
Related Concept Videos
Atypical Pneumonia
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Acute Pyelonephritis II: Diagnostic Studies and Management